Aethlon Medical (AEMD) Posts Smaller Q3 Loss

Aethlon Medical (NASDAQ: AEMD) reported Q3 EPS of ($0.28), $0.75 better than the analyst estimate of ($1.03). Revenue for the quarter came in at $413.5 thousand versus the consensus estimate of $190 thousand.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery